BlackRock Health Sciences Trust (NYSE:BME) Share Price Crosses Above 50 Day Moving Average – Time to Sell?

BlackRock Health Sciences Trust (NYSE:BME)’s share price passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $39.22 and traded as high as $39.96. BlackRock Health Sciences Trust shares last traded at $39.3350, with a volume of 67,527 shares.

BlackRock Health Sciences Trust Stock Down 1.7%

The business’s 50 day moving average is $39.22 and its 200-day moving average is $40.56.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of BlackRock Health Sciences Trust by 285,436.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 4,046,055 shares of the company’s stock valued at $166,414,000 after buying an additional 4,044,638 shares in the last quarter. 1607 Capital Partners LLC boosted its holdings in shares of BlackRock Health Sciences Trust by 49.5% in the 4th quarter. 1607 Capital Partners LLC now owns 229,260 shares of the company’s stock valued at $9,429,000 after buying an additional 75,958 shares in the last quarter. Invesco Ltd. boosted its holdings in shares of BlackRock Health Sciences Trust by 7.6% in the 3rd quarter. Invesco Ltd. now owns 217,169 shares of the company’s stock valued at $8,085,000 after buying an additional 15,381 shares in the last quarter. Bank of America Corp DE boosted its holdings in shares of BlackRock Health Sciences Trust by 18.8% in the 3rd quarter. Bank of America Corp DE now owns 216,404 shares of the company’s stock valued at $8,057,000 after buying an additional 34,218 shares in the last quarter. Finally, Royal Bank of Canada boosted its holdings in shares of BlackRock Health Sciences Trust by 13.0% in the 4th quarter. Royal Bank of Canada now owns 160,464 shares of the company’s stock valued at $6,600,000 after buying an additional 18,442 shares in the last quarter.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.